The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou.

ABSTRACT:

Background

Dyslipidemia is increasingly common in people living with HIV (PLHIV), thereby increasing the risk of cardiovascular events and diminishing the quality of life for these individuals. The study of blood lipid metabolism of PLHIV has great clinical significance in predicting the risk of cardiovascular disease. Therefore, this study aims to examine the blood lipid metabolism status of HIV-infected patients in Huzhou before and after receiving highly active antiretroviral therapy (HAART) and to explore the impact of different HAART regimens on dyslipidemia.

Method

PLHIV confirmed in Huzhou from June 2010 to June 2022 was included. The baseline characteristics and clinical data during the follow-up period were collected, including some blood lipid indicators (total cho

SUBMITTER: Wang Y 

PROVIDER: S-EPMC11414983 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature